Loading insider details...
Beta
Latest Form 4 (Jun 15, 2026): Grant/Award of 87,900 FATE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 87,900 | n/a |
| May 30, 2025 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 55,000 | n/a |
| Jun 11, 2024 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 40,000 | n/a |
| May 17, 2024 | Gritstone bio, Inc. (GRTS) | Grant/Award | 27,128 | n/a |
| Feb 5, 2024 | Gritstone bio, Inc. (GRTS) | Grant/Award | 40,000 | n/a |
| Jun 7, 2023 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 40,000 | n/a |
| Jun 13, 2022 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 8,650 | n/a |
| Jun 6, 2022 | FATE THERAPEUTICS INC (FATE) | Sale | 1,483 | $33.8K |
| Jun 4, 2021 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 2,681 | n/a |
| May 5, 2020 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 16,000 | n/a |